Advancing Dry AMD Care with Microcurrent Technology - The Latest Insights You Need to Know on VAs, Contrast Sensitivity, and OCT Imaging
Thursday, July 3, 2025
8:00 AM - 9:00 AM
Description
Over 2 million Canadians living with Dry AMD need help with their vision. Now, there’s hope!
Microcurrent technology is the first-ever Health Canada approved treatment with an indication to improve visual function in Dry AMD patients.
- The latest updates on progress + real-world clinical results
- Inspiring patient success cases + OCT imaging
- Interactive Q+A with the audience
Breakfast provided and sponsored by: MacuMira Therapeutic Inc.
Track
Stream: OD
CE
Not accredited | Session non-accréditée